Navigation Links
Landauer, Inc. Reports Fiscal 2013 Second Quarter Results
Date:5/6/2013

dited)(Dollars in Thousands)March 31,2013September 30,2012ASSETSCurrent assets:Cash and cash equivalents$

11,054$

17,633Receivables, net of allowances of $1,133 and $1,088,  respectively36,41935,165Inventories9,7188,638Prepaid income taxes4,9022,148Prepaid expenses and other current assets4,2673,975Current assets66,36067,559Property, plant and equipment, at cost105,883101,375Accumulated depreciation and amortization(51,256)(46,983)Net property, plant and equipment54,62754,392Equity in joint ventures22,68324,108Goodwill106,746106,717Intangible assets, net of accumulated amortization of $11,395 and $9,696, respectively36,09137,402Dosimetry devices, net of accumulated depreciation of $9,511 and $8,879, respectively6,4366,189Other assets6,1015,758Assets$

299,044$

302,125LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable$

6,541$

9,656Dividends payable5,4035,345Deferred contract revenue14,41314,947Accrued compensation and related costs6,9388,260Other accrued expenses7,7897,096Current liabilities41,08445,304Non-current liabilities:Long-term debt143,260141,347Pension and postretirement obligations17,82117,586Deferred income taxes16,17915,733Other non-current liabilities1,1061,053Non-current liabilities178,366175,719Stockholders' equity:Preferred stock, $.10 par value per share, authorized 1,000,000 shares; none issued00Common stock, $.10 par value per share, authorized 20,000,000 shares; 9,562,320 and 9,493,368 shares issued and outstanding at March 31, 2013 and September 30, 2012, respectively956949Additional paid in capital37,06335,898Accumulated other comprehensive loss(7,324)(5,272)Retained earnings47,68548,142Landauer, Inc. stockholders' equity78,38079,717Noncontrolling interest1,2141,385Stockholders' equity79,59481,102Liabilities and Stockholders' Equity$

299,044$

302,125 

 Reconciliation of Net Income to Adjusted Earnings before
'/>"/>

SOURCE Landauer, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Second Quarter 2013 Results
2. Landauer, Inc. Reports Fiscal 2013 First Quarter Results
3. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
4. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results
5. Landauer, Inc. Appoints Ronald Zilkowski To Vice President, Corporate Controller And Chief Accounting Officer
6. Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement
7. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
8. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
9. Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
10. IRIDEX Reports 2013 First Quarter Results
11. Masimo Reports First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... JUNCTION, N.J. , Jan. 23, 2015  CytoSorbents ... company commercializing its CytoSorb® extracorporeal cytokine adsorber to ... patients, announced the receipt of $385,642, net of ... participant of the Technology Business Tax Certificate Transfer ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... at 8 am versus placebo: - 25,/ - ... Blood pressure reduction dependent on vaccine dose and ... today at the Seventeenth European,Meeting on Hypertension in ... Italy, June 17, 2007 -,Cytos Biotechnology AG (SWX:CYTN) ...
... WIRE)--Jun 18, 2007 - Advanced Viral,Research Corp. ... today that preliminary findings from its ongoing,Phase ... AVR118,appears to have clinical activity in reducing ... dermatologic,dermabrasion., The Phase II open label dermatological ...
Cached Medicine Technology:Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 2Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 3Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 4Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 5Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 6Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 7Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 8Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 9Advanced Viral Research Corp. Announces Positive Preliminary,Findings from Ongoing Phase II Dermatological Study 2
(Date:1/22/2015)... January 22, 2015 Four years since the release ... which coincided with the marriage of Avasa & Matthew Love – ... which is scheduled for release through White Swan Records on February ... there is a sacred path available to all of us to ...
(Date:1/22/2015)... Mass. (PRWEB) January 22, 2015 EBSCO ... (AMA) are expanding their relationship in an effort to ... around the world. While EBSCO has long made AMA journals ... a sales agent for The JAMA Network. , ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for ... its latest collection of wedding dresses , and launches ... is the wedding dress on your big day; the wedding ... Every bride wants to find the most suitable wedding dress. ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining the ... reducing the costs of an auto insurance policy . ... get lower prices for their vehicle insurance policies. The safety a ... policy costs. Because of this, drivers should always carry a ...
(Date:1/22/2015)... 22, 2015 State Forestry Institute of ... system with support from GEOSYSTEMS, a dedicated Hexagon Geospatial ... will leverage Hexagon Geospatial’s ERDAS APOLLO for ... well as point clouds and documents. This effort will ...
Breaking Medicine News(10 mins):Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... grant support, investigators at Nationwide Children,s Hospital plan to ... leads to the development of a devastating brain tumor, ... Center for Childhood Cancer at The Research Institute at ... the Matthew Larson Foundation for this research. ...
... 1 (HealthDay News) -- Screening college athletes for heart conditions ... sudden cardiac death, according to a new study. ... heart abnormality or symptoms that required further screening, prompting researchers ... in sports. Every year in the United States, 60 ...
... Gardner HealthDay Reporter , WEDNESDAY, June 1 ... researchers were able to find previously undetected changes in ... had been diagnosed with mild brain injuries sustained from ... "absolutely not there yet," Christine Mac Donald, lead author ...
... a newer, more precise form of radiation therapy, ... hormone therapy than using three-dimensional radiation therapy, according ... of the International Journal of Radiation OncologyBiologyPhysics ... Society for Radiation Oncology (ASTRO). Three-dimensional radiation ...
... -- Newly diagnosed cancer patients frequently face hurdles in ... to new research from the Perelman School of Medicine ... Saturday, June 4 at the 2011 annual meeting of ... with private health insurance had difficulty scheduling an appointment, ...
... MAYWOOD, Ill. -- Baseline concussion tests given to hundreds ... some cases, according to a Loyola University Health System ... rate, meaning a test shows an athlete has recovered, ... cognitive impairments from the concussion. This could increase risks ...
Cached Medicine News:Health News:New grant to study how pediatric brain tumor, ependymoma, develops 2Health News: Experts Recommend Cardiac Screening for College Athletes 2Health News:Hi-Tech Scan Detects Soldiers' Head Injuries 2Health News:Hi-Tech Scan Detects Soldiers' Head Injuries 3Health News:Two-thirds of newly diagnosed cancer patients unable to obtain oncology appointments 2Health News:Does baseline concussion testing really reduce risks to athletes? 2
4 mm wide tip....
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Double-ended. Designated most popular model or size....
Designated most popular model or size. Double-ended. 2 mm wide....
Medicine Products: